Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque
NCT ID: NCT04921371
Last Updated: 2023-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
157 participants
INTERVENTIONAL
2019-10-08
2019-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Twelve Week Study of Experimental Mouth Rinses
NCT05120141
A Study of Experimental Mouthwashes
NCT05121909
A Study of Virtually Supervised Mouthwash and Interdental Brushes
NCT05756673
A Twelve Week Study of Prototypes Mouth Rinses
NCT05526586
A Four-Week Study to Measure the Effectiveness of an Experimental Mouthwash Used After Teeth Cleaning
NCT01462110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Reference Group
Participants who are identified as healthy will be a comparison group. This group will participate in the examinations and plaque sampling only and will not receive a prophylaxis or product.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
5% Hydroalcohol Mouthrinse (Negative control)
Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 milliliter (mL) of 5 percent (%) Hydroalcohol Mouthrinse twice daily (morning and evening) up to 6 weeks.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
5% Hydroalcohol Mouthrinse
Participants will use 20 mL of 5% Hydroalcohol Mouthrinse for 30 seconds after brushing twice daily.
Listerine® Cool Mint® (Positive control)
Participants after brushing with Colgate® Cavity protection toothpaste and Concept curve winter series Toothbrush will rinse mouth for 30 seconds with 20 mL of Listerine® Cool Mint® twice daily (morning and evening) up to 6 weeks.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Listerine® Cool Mint®
Participants will use 20 mL of Listerine® Cool Mint® mouth rinse for 30 seconds after brushing twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
Mouthrinse Prototype 1
Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 mL of Mouthrinse Prototype 1 twice daily (morning and evening) up to 6 weeks.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
Mouthrinse Prototype 1
Participants will use 20 mL of Mouthrinse Prototype 1 for 30 seconds after brushing twice daily.
Mouthrinse Prototype 2
Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 mL of Mouthrinse Prototype 2 twice daily (morning and evening) up to 6 weeks.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
Mouthrinse Prototype 2
Participants will use 20 mL of Mouthrinse Prototype 2 for 30 seconds after brushing twice daily.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colgate® Cavity Protection Toothpaste
Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.
Listerine® Cool Mint®
Participants will use 20 mL of Listerine® Cool Mint® mouth rinse for 30 seconds after brushing twice daily.
Concept Curve Winter Series Toothbrush
Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.
5% Hydroalcohol Mouthrinse
Participants will use 20 mL of 5% Hydroalcohol Mouthrinse for 30 seconds after brushing twice daily.
Mouthrinse Prototype 1
Participants will use 20 mL of Mouthrinse Prototype 1 for 30 seconds after brushing twice daily.
Mouthrinse Prototype 2
Participants will use 20 mL of Mouthrinse Prototype 2 for 30 seconds after brushing twice daily.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A minimum of 20 gradable teeth including 4 molars with scorable facial and lingual surfaces. Teeth that are grossly carious, extensively restored, orthodontically banded, abutments, exhibiting severe generalized cervical and/or enamel abrasion, teeth with veneers, or third molars will not be included in the tooth count
* A mean gingival index greater than or equal to (\>=) 1.95 per the Modified Gingival Index at Baseline (for those in the randomized treatment group)
* A mean gingival index less than or equals to (\<=) 0.75 per the Modified Gingival Index at Baseline (for those in the healthy reference group)
* A mean plaque index \>= 1.95 per the 6 site Turesky modification of the Quigley-Hein Plaque Index at Baseline (for those in randomized treatment groups)
* Greater than or equal to 10 percent (%) bleeding sites at baseline (for those in randomized treatment groups)
Exclusion Criteria
* Dental prophylaxis within four weeks prior to Screening/Baseline 1 visit
* More than three sites that have periodontal pockets depths measuring 5mm or greater in depth
* Teeth having periodontal pocket depths measuring more than 3 mm in depth (healthy reference group)
* History of medical conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
* Use of Antibiotics, anti-inflammatory or anticoagulant therapy, phenytoin sodium or diphenylhydantoin, calcium channel blockers, cyclosporin A, immunostimulants/ immunomodulators during the study or within the one month prior to the Baseline 1 exam. Intermittent use of certain anti-inflammatory medication is acceptable at the discretion of the Investigator
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Consumer Inc. (J&JCI)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffery Milleman, DDS
Role: PRINCIPAL_INVESTIGATOR
Salus Research, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Salus Research, Inc.
Fort Wayne, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Min K, Glowacki AJ, Bosma ML, McGuire JA, Tian S, McAdoo K, DelSasso A, Fourre T, Gambogi RJ, Milleman J, Milleman KR. Quantitative analysis of the effects of essential oil mouthrinses on clinical plaque microbiome: a parallel-group, randomized trial. BMC Oral Health. 2024 May 18;24(1):578. doi: 10.1186/s12903-024-04365-9.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCSORC001793
Identifier Type: OTHER
Identifier Source: secondary_id
CCSORC001793
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.